Drug-Target Information | ||||||||
---|---|---|---|---|---|---|---|---|
Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
at9283 | aurora kinase a | small molecule | Clinical trial target | TTD , drugbank , DGIDB | leukemia[MeSHID:D007938] Neoplasms[MeSHID:D009369] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Malignant Neoplasms[MeSHID:D009369] |
0.59 | investigational,phase 3 | unknown |
at9283 | aurora kinase a | small molecule | Clinical trial target | TTD , drugbank , DGIDB | leukemia[MeSHID:D007938] Neoplasms[MeSHID:D009369] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Malignant Neoplasms[MeSHID:D009369] |
0.59 | investigational,phase 3 | inhibitor |
at9283 | aurora kinase b | small molecule | Clinical trial target | TTD , drugbank , DGIDB | leukemia[MeSHID:D007938] Neoplasms[MeSHID:D009369] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Malignant Neoplasms[MeSHID:D009369] |
0.49 | investigational,phase 3 | unknown |
at9283 | aurora kinase b | small molecule | Clinical trial target | TTD , drugbank , DGIDB | leukemia[MeSHID:D007938] Neoplasms[MeSHID:D009369] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Malignant Neoplasms[MeSHID:D009369] |
0.49 | investigational,phase 3 | inhibitor |
click here to return to the previous page |